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Abstract
Background: Increased production and accumulation of methylglyoxal (MGO), as well as increased modification of proteins
by glycoxidation, are hallmarks of aging and diabetes. MGO was shown to modify proteins and to contribute to the
accumulation of damaged proteins that can be toxic to cells. However, the effect of MGO on the cell systems responsible for
repairing or degrading damaged proteins is still unclear. In this study, the effect of MGO on the function of the ubiquitin-
proteasome system (UPS) and on molecular chaperones, two cooperative mechanisms associated with protein quality
control, was investigated.
Principal Findings: In this work it is shown that treatment of cells with MGO leads to accumulation of ubiquitin conjugates
and depletion of free ubiquitin. Moreover, MGO significantly decreases the proteolytic activity of the 20S proteasome. Data
further shows that MGO decreases the levels of the molecular chaperones Hsc70 and Hsp90 and leads to accumulation of
CHIP-, Hsp40- and ubiquitin-containing aggregates. The formation of large aggregates containing CHIP is a consequence of
its binding to misfolded proteins and to molecular chaperones. Moreover, dysfunction of the chaperones/CHIP/UPS axis is
associated with accumulation of oxidized and argpyrimidine-modified proteins, which is likely to be associated with
decreased cell viability. Interestingly, data further shows that MGO-induced stress induces the activation of heat shock
factor-1 (Hsf-1), the main transcription factor involved in the regulation of the expression of heat shock proteins (HSPs) and
cell response to stress.
Conclusions: The data obtained in this work suggests that MGO impairs both the UPS and the protein quality control
dependent on CHIP and molecular chaperones, leading to accumulation of toxic aggregates and increased cell death.
However, these MGO-induced changes appear to elicit a response from the Hsf-1 system, which is crucial to help cells to
cope with cellular stress and to re-establish homeostasis.
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Introduction
MGO is a highly reactive a-oxoaldehyde that is formed in cells
primarily from the triose phosphate intermediates of glycolysis,
dyhydroxyacetone phosphate and glyceraldehyde 3-phosphate [1].
This by-product of glycolysis induces rapid and non-enzymatic
modification of free amino groups of lysine and arginine residues
of proteins, leading to the generation of advanced glycation end
products (AGEs) [2]. The posttranslational modification of
proteins by MGO is known to contribute to aging, as well as to
a number of diseases, including cancer, diabetes and other
disorders [1]. Indeed, hyperglycaemia triggers enhanced produc-
tion of MGO on diabetes [1,3], leading to vascular dysfunction
[4], while AGEs exacerbate and accelerate a number of
characteristics of many age-related diseases [5,6].
MGO is known to induce aggregation and structural modifi-
cations in proteins through cross-linking and formation of
chemical adducts [7,8]. In eukaryotic cells, the proteasome
contributes to prevent the accumulation of non-functional,
potentially toxic proteins. This proteolytic system is of particular
importance in protecting cells against harsh conditions, such as
heat shock, glycation or oxidative stress [9], and is an important
player in the protein quality control system in eukaryotic cells.
However, when the generation of obsolete proteins exceeds the
capacity of the cell to degrade them, there is a progressive
accumulation of damaged proteins, which often become insoluble
over time and are potentially toxic to cells [9]. Accumulation of
damaged proteins, ultimately, occurs when the proteolytic systems
and molecular chaperones, which normally prevent aggregation
(for example, Hsc70 and Hsp90) [10,11], cannot keep up with the
rate of production of misfolded or otherwise damaged proteins.
The carboxy terminus of the Hsc70-interacting protein (CHIP)
is a key player in protein quality control since it is a molecular link
between chaperones and the UPS. Indeed, CHIP has both a
tetratricopeptide repeat (TPR) motif and a U-box domain [12].
The TPR motif associates with chaperones, such as Hsp40, Hsc70
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Thus, CHIP has a critical role in protein quality control by
ubiquitinating misfolded or post-translationally modified proteins
through interaction with molecular chaperones [13].
It has been suggested that the activity of the proteasome can be
compromised upon aging [14] and diabetes [15]. For example, the
levels of the proteasome activator PA28 are decreased in muscle
extracts of diabetic rats [16], which might result in accumulation
of glycated and toxic proteins, typically observed in diabetic
tissues. Furthermore, formation of amyloid-aggregates, which is
usually associated with aging and diabetes, is highly enhanced by
MGO and other aldehydes [17] and this is known to impair the
UPS, leading to apoptosis [18]. On the other hand, it has been
suggested that UPS activity decreases with aging, which may
further account for the accumulation of modified and toxic
proteins in cells, contributing to cell injury and death [14].There is
also increasing evidence showing that molecular chaperones, such
as a-crystallin and Hsp27 [19,20], are themselves major targets of
MGO-induced modification and aggregation. These and other
evidences indicate that age- and diabetes-dependent accumulation
of MGO is likely to account for impairment of the protein-quality
control mechanism. However, the effect of MGO in the function
of UPS and on molecular chaperones is still not clear.
Herein, it is shown that increased levels of MGO lead to
accumulation of ubiquitin conjugates and depletion of free
ubiquitin in the cell. The accumulation of ubiquitin conjugates is
presumably due to both MGO-induced impairment of UPS and
MGO-induced disruption of chaperones. Data presented in this
work further shows that MGO downregulates Hsc70 and Hsp90
and promotes the formation of large aggregates containing Hsp40,
CHIP and ubiquitin. Consistently, increased levels of MGO lead
to accumulation of modified proteins and decreased cell viability.
Moreover, MGO-induced cell damage elicits a heat-shock
response by activation of Hsf-1, presumably as part of a more
general strategy of cell response to stress.
Results
MGO impairs proteasome activity and leads to
accumulation of ubiquitin conjugates
Increased production and accumulation of MGO have been
associated with cell and tissue dysfunction on diabetes and aging
[1], both characterized by decreased proteasome activity [14,16].
However, the putative effect of MGO on the proteasome activity
and on the accumulation of modified proteins remains to be
clarified.
To evaluate the effect of MGO in the proteasome activity, we
used a human retinal pigment epithelium cell line (ARPE-19). This
cell type represents an appropriate model for this study since it has
a very active and functional UPS [21,22]. Moreover, the retinal
pigment epithelium (RPE) has a high rate of glucose consumption
and its ubiquitin-proteasome system has been shown to be affected
during aging and diabetes [5,6,23]. Indeed, formation of AGEs is a
trigger for the onset of age-related phenotypes on choroid and
RPE cells [6].
Prior to test the proteasome activity, we observed that
incubation of RPE cells with 1 mM or 3 mM MGO for 3 hours
resulted in an intracellular accumulation of MGO of 0.560.12
and 0.760.14 nmol MGO/mg protein, respectively, which
corresponds to a 1.8 and 2.3 fold increase as compared to control
(Figure 1A). Although the high concentrations used in this work
are not found in the plasma and tissues, we observed that they
induce an intracellular accumulation of MGO that is consistent
with the levels found in tissues of diabetic animals [24]. Moreover,
the obtained intracellular levels of MGO using these concentra-
tions are similar to those observed in other studies using cell
culture systems [25].
To assess the 20S proteasome activity, ARPE-19 cells were
treated with MGO and the cell extracts were used to measure the
three peptidase activities of the 20S proteasome using fluorogenic
substrates. Data shows that these MGO concentrations decrease
the chymotrypsin-like and caspase-like activities of the 20S
proteasome, by about 32% and 17%, respectively (Figure 1B).
Immunoblot analysis of ARPE-19 cell extracts treated with MGO
revealed that MGO increases the accumulation of ubiquitin
conjugates and decreases the levels of free ubiquitin (Figure 1C).
This result is comparable to data obtained in the presence of a
proteasome inhibitor (such as MG132) and suggests that MGO
impairs proteasome activity.
Considering that the fluorogenic substrate used to assess the
chymotrypsin-like activity of the proteasome may also be a
substrate for other chymotrypsin-like proteases, such as calpains
[26], one may not exclude the role of MGO in the inhibition of
other proteases. Moreover, MGO may also exert some effects on
Figure 1. MGO decreases the 20S proteasome activity, depletes free ubiquitin and leads to accumulation of ubiquitin conjugates.
(A) ARPE-19 cells were treated with 1 mM or 3 mM of MGO for 3 hours. Cells were then lysed and the intracellular levels of MGO were determined by
HPLC after derivatization with DDB. The results represent the mean 6 SD of at least three independent experiments. * p,0.05, significantly different
from control (one-way ANOVA). (B) ARPE-19 cells were treated with 3 mM MGO for 3 hours and the cell extracts were used to measure the proteolytic
activities of the 20S proteasome (chymotrypsin-like, caspase-like and trypsin-like activities) using specific fluorogenic substrates. The results
correspond to the measurement at 30 minutes of activity and represent the mean 6 SD of at least three independent experiments. ** p,0.01,
significantly different from control; paired T test. (C) ARPE-19 cells were treated with 1 mM MGO, 3 mM MGO or 20 mM MG132 for 3 hours and the
proteins were separated by SDS-PAGE, transferred to PVDF membranes and probed with monoclonal antibodies against ubiquitin and actin.
doi:10.1371/journal.pone.0013007.g001
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of ubiquitin-conjugating or ubiquitin-ligase enzymes, inducing
changes on the total levels of ubiquitin-conjugates in the cell.
However, the fact that MG132 and epoxomicin inhibited by over
90% the degradation of fluorogenic substrates, specifically Suc-
LLVY-AMC, (data not shown) strongly suggests that the major
contribution for the degradation of these substrates occurs indeed
via proteasomal degradation.
MGO decreases the levels of Hsc70 and Hsp90
MGO is known to induce modification of proteins by
glycoxidation [2,27,28,29]. Accumulation of damaged proteins
can be toxic and interfere with normal cell function. Therefore,
repair or elimination of MGO- or otherwise-damaged proteins is
critical to ensure proper cell functioning and survival. This
function is supported by a complex quality control mechanism that
relies on molecular chaperones and UPS, which can either refold
damaged proteins or direct them to proteasomal degradation. The
molecular chaperones Hsc70 and Hsp90 bind to unfolded proteins
and both contribute to regulate the protein quality control
[9,30,31,32]. Therefore, it is likely that destabilization of these
chaperones may compromise the protein quality control. Data
obtained in this study shows that in addition to inhibiting the
proteasome, MGO induces a decrease in the levels of Hsc70 and
Hsp90 proteins (Figures 2A, 2B and 2C).
MGO induces the formation of CHIP-, Hsp40- and
ubiquitin-containing aggregates
Hsp40 and CHIP are crucial regulators of the protein quality
control [30,31,33]. Damaged proteins are often recognized and
bind to Hsp40, which in turn recruit Hsc70. Hsp40 functions in
cooperation with the co-chaperone CHIP, which has ubiquitin
ligase activity and, therefore, is able to ubiquitinate damaged
proteins, promoting its UPS-dependent degradation [9]. Data
represented in Figures 3A, 3B and 3C show that MGO strongly
increases, in a time- and dose-dependent manner, the accumula-
tion of bands with high molecular weights that present
immunoreactivity for CHIP and Hsp40 antibodies. Moreover,
we observed that MGO increases the ubiquitination of CHIP- and
Hsp40-positive aggregates (Figures 3C and 3D). However,
ubiquitination on its own does not fully explain the posttransla-
tional modification of CHIP-containing aggregates, since MG132
strongly increases ubiquitination of the protein and does not
induce accumulation of bands with high molecular weights,
consistent with CHIP-containing aggregates. We suggest that these
high molecular weight bands correspond to ubiquitinated
substrates that undergo MGO-induced post-translational modifi-
cations, ending up in large aggregates containing ubiquitinated
proteins, chaperone and co-chaperone complexes, including
Hsp40 and CHIP. This could be the result of the cooperative
action of chaperones and UPS in rescuing or degrading misfolded
and/or post-translationally modified substrates. It is conceivable
that some of these aggregates will became insoluble, accounting for
age- and diabetes-related cell damage. To further pursue this issue,
ARPE-19 cells were transfected with a mutant CHIP that cannot
bind chaperones (CHIP K30A) or with a mutant CHIP with no
ubiquitin ligase activity (CHIP H260Q). Data shows that the
accumulation of bands with high molecular weight, with reactivity
for CHIP, decreases when CHIP does not contain chaperone-
binding affinity (Figure 3E). Conversely, accumulation of high
molecular weight complexes is potentiated by overexpression of
CHIP with no ubiquitin ligase activity (Figure 3E). This suggests
that the accumulation of CHIP-containing high molecular weight
complexes is dependent on the two domains of the protein
(ubiquitin-ligase and chaperone-binding) and is likely to be the
result of CHIP being trapped in ubiquitinated complexes
containing molecular chaperones and damaged/misfolded
proteins.
MGO leads to accumulation of modified proteins and
decreases the cell viability
Considering that MGO impairs the ubiquitin-proteasome
system and disrupts the chaperone axis, we suggest that MGO is
likely to disrupt the protein quality control system in the cell,
leading to a potentially toxic accumulation of damaged proteins.
Indeed, we observed that MGO strongly increases the levels of
oxidized proteins (Figure 4A). Consistently, we also observed
increased accumulation of AGEs in the presence of MGO, as
revealed by increased immunoreactivity of whole protein extracts
against an anti-argpyrimidine antibody (Figure 4B). Of signifi-
cance, accumulation of damaged and toxic proteins is accompa-
nied by decreased cell viability (Figure 4C).
MGO elicits a heat-shock response and activates Hsf-1
Stimuli that induce cell stress and protein damage normally
activate sensing mechanisms and various forms of cell response to
stress, which often include a dramatic change in the pattern of
gene expression and increased synthesis of molecular chaperones.
Figure 2. MGO decreases the levels of Hsc70 and Hsp90. (A, B and C) ARPE-19 cells were treated with 1 mM MGO or 3 mM MGO for 3 hours
and the cell lysates were analyzed by western blotting using anti-Hsc70 (A), anti-Hsp90 (B) and anti-actin antibodies. The quantified results represent
the mean 6 SD of at least three independent experiments. *** p,0.001,
## p,0.01,
### p,0.001, significantly different from control; one-way
ANOVA (Dunnet’s post hoc test) (C).
doi:10.1371/journal.pone.0013007.g002
MGO in Protein Quality Control
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e13007Increased expression of heat-shock proteins generally results in
repair of modified proteins, promoting cell survival [34]. The
inducible expression of HSPs is mainly regulated by the heat shock
transcription factor-1 (Hsf-1), that induces transcription of various
heat shock genes.
As previously shown, MGO constitutes a potent stress-inducer
by impairing UPS activity, leading to the accumulation of
damaged and modified proteins in the cell. On the other hand,
Hsf-1 is a crucial transcription factor activated under conditions of
stress, including accumulation of damaged proteins. Thus, we
assessed whether activation of Hsf-1 is part of the cell response to
the noxious effects induced by MGO.
Oligomerization and phosphorylation of Hsf-1, as well as gain
of DNA binding activity, are all well described hallmarks for
activation of Hsf-1 [35,36]. Indeed, in this study we show that Hsf-
1 is mostly present in the monomeric/inactive form under normal
conditions. However, MGO induces the formation of Hsf-1
homodimers, followed by the formation of Hsf-1 homotrimers
(Figure 5A), suggesting Hsf-1 activation. It should be noted that
these polymeric forms of Hsf-1 are preserved during the
immunoblot procedure due to the low content (1–2%) of b-
mercaptoethanol on the denaturation buffer. Consistently, a slight
shift on the molecular weight of Hsf-1 is also observed in the
presence of MGO (Figure 5B), which may be due to increased
phosphorylation under these conditions. To further evaluate the
activation of Hsf-1 by MGO-induced stress, we examined the
ability of Hsf-1 to bind heat-shock elements (HSE) on DNA and
activate transcription of the genes under the control of this
conserved sequence. Indeed, through an HSE-luciferase gene
reporter assay, we observed that MGO specifically increases the
transcriptional activity of Hsf-1 (Figure 5C). Moreover, an increase
in the levels of mRNA and protein of the molecular chaperones
Hsc70, Hsp70 and Hsp90 further confirm the activation of Hsf-1
by MGO, indicating the activation of a heat-shock response
following the exposure to MGO. Interestingly, MGO appears to
have a biphasic effect on the regulation of molecular chaperones.
In an early stage, MGO decreases the mRNA and protein levels of
these proteins (up to 5 h of incubation). However, this response is
reverted for longer periods of incubation with MGO (Figure 5D,
5E, 5F), suggesting the mounting of a cell response to stress, which
is likely to be triggered by Hsf-1. This response seems to be
somewhat specific as we were not able to detect increased levels of
Figure 3. MGO induces formation of large aggregates containing ubiquitin, CHIP and Hsp40. (A) ARPE-19 cells were treated with 1 mM
MGO or 3 mM MGO for 3 hours and the cell lysates were analyzed by western blotting using specific antibodies against CHIP and actin. (B) ARPE-19
cells were transfected with myc-CHIP wt and treated with 3 mM MGO for 15, 30, 50, 79 and 90 minutes. Proteins were separated by SDS-PAGE,
transferred to PVDF membranes and probed for c-myc. (C) ARPE-19 cells were treated with 1 mM MGO or 3 mM MGO for 3 hours. The cell lysates
were used to immunoprecipitate Hsp40 and immunoblot the immunoprecipitates against ubiquitin. (D) ARPE-19 cells were transfected with myc-
CHIP wt and treated with 3 mM MGO for 3 hours. c-myc (CHIP) was immunoprecipitated and the immunoprecipitates were probed using a
monoclonal antibody against ubiquitin. (E) ARPE-19 cells were transfected with c-myc CHIP wt, c-myc CHIP K30A or c-myc CHIP H260Q. Cells were
subsequently treated with 3 mM MGO for 3 hours and the cell lysates were immunoblotted for c-myc and actin.
doi:10.1371/journal.pone.0013007.g003
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the control of Hsf-1) and GAPDH (another cytoplasmic protein)
(Figure 5F).
Hsp90-containing multichaperone complexes appear to be the
most relevant repressors of Hsf-1 activity [37]. Indeed, in this work
we show that oligomerization of Hsf-1 is accompanied by a
dramatic decrease in the interaction between Hsp90 and Hsf-1
(Figure 5G), highlighting the critical activation of Hsf-1 in response
to MGO.
Of great biological significance, we further noted that activation
of Hsf-1 and increased expression of molecular chaperones is
accompanied by an increase in cell viability, which is likely to
indicate adaptation to the noxious effects of MGO (Figure 5H).
Discussion
Increased production of MGO, increased modification of
proteins by glycoxidation and accumulation of damaged proteins
are all hallmarks of aging and of a number of diseases, such as
diabetes and cancer [1,5]. MGO is known to be toxic and to
interfere with a plethora of critical mechanisms in the cell. For
example, MGO impairs the mitochondria-respiratory chain and
increases the production of reactive oxygen species, particularly
the anion superoxide, contributing to increased oxidation of
proteins [38,39,40]. On the other hand, MGO reacts with free e-
NH2 groups of basic amino acid residues, through glycation,
altering the structure and function of proteins [41]. These and
other posttranslational modifications induce exposure of hydro-
phobic patches of the proteins and loss of secondary and tertiary
structure [41,42]. These changes were proposed to act as a
recognition signal for degradation by the proteasome [43,44,45].
Canonically, the recognition of the exposed hydrophobic domains
of modified proteins is mediated by molecular chaperones, such as
Hsc70 and Hsp90. Binding of chaperones is often suggested to
recruit the ubiquitin ligase CHIP, which ubiquitinates the
modified proteins and targets them for proteasomal degradation
[9]. However, the function of the proteasome has also been
reported to be impaired upon aging, which may account for
inefficient removal of damaged proteins [41,46,47]. For example,
oxidative inactivation of the proteasome was reported in many
types of cells and proteasome activity was shown to decrease in
glyoxal-treated cells as compared to controls [41]. Moreover,
hyperglycaemia-induced formation of MGO was shown to
covalently modify the 20S proteasome, decreasing its activity in
cultured endothelial cells and extracts of diabetic kidneys [48].
Consistently, in this study we show that MGO impairs the UPS
and destabilizes several molecular chaperones that are crucial for
the protein quality control. These impairments are likely to
contribute for the accumulation of modified proteins and
decreased cell viability.
Indeed, a number of independent studies have shown that
MGO modifies and destabilizes several molecular chaperones,
such as Hsp27 and a-crystallin [19,20,49,50,51,52]. Despite some
controversial studies, it is becoming increasingly clear that
molecular chaperones and co-chaperones constitute a group of
proteins that can be critically affected by MGO. Indeed, in this
work, we show that Hsp40, Hsc70, Hsp90 and CHIP are all
destabilized by MGO. The protein levels of Hsc70 and Hsp90
decrease in the presence of MGO. On the other hand, CHIP and
Hsp40 aggregate following treatment with MGO. These findings
led us to hypothesize that, in addition to other established toxic
effects, MGO acts by disrupting the cell protein quality control
system. Indeed, we show that treatment of cells with MGO leads
to the formation of Hsp40- and CHIP-containing ubiquitinated
aggregates and that the overexpression of a ligase-dead CHIP
increases the levels of CHIP-positive aggregates. Moreover, data
from overexpression of a mutant CHIP, which does not bind
chaperones, suggests that formation of these aggregates is
mediated by ancillary chaperones that bind to CHIP. These
findings led us to suggest that CHIP is probably trapped in
aggregates of modified proteins, which are recognized by the
chaperone-binding site of CHIP and are, at least in part, targeted
for degradation mediated by the ubiquitin ligase activity of this
protein. Data also emphasizes the dual role of CHIP in the
recognition of damaged proteins and in the targeting of these
proteins for degradation. Nevertheless, overexpression of CHIP is
not sufficient to entirely compensate for the accumulation of
modified proteins, thus accounting for increased cell toxicity.
Indeed, we show that impairment of UPS and destabilization of
molecular chaperones is accompanied by decreased cell viability.
Figure 4. MGO induces accumulation of oxidized and argpyrimidine-modified proteins and decreases cell viability. (A) ARPE-19 cells
were treated with 1 mM MGO or 3 mM MGO for 3 hours and the cell lysates were used to derivatize proteins with DNPH. Derivatized proteins were
separated by SDS-PAGE, transferred to PVDF membranes and probed with an antibody against dinitrophenylhydrazone derivatives. (B) ARPE-19 cells
were treated with 1 mM or 3 mM MGO for 3 hours and the cell lysates were immunoblotted for argpyrimidine and actin. (C) ARPE-19 cell were
treated with 1 mM MGO or 3 mM MGO for 3 hours and used to assess cell viability through the MTT colorimetric assay. The quantified results
represent the mean 6 SD of at least three independent experiments. * p,0.05, significantly different from control; one-way ANOVA (Dunnet’s post
hoc test).
doi:10.1371/journal.pone.0013007.g004
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PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e13007Figure 5. MGO-induced stress activates Hsf-1 through increased oligomerization and DNA-binding, eliciting a cell response to
stress. (A) ARPE-19 cells were treated with 50 mM CHX together with 1 mM MGO for 1, 2, 3, 4 or 5 hours and the cell lysates were analyzed by
western blot using specific antibodies against Hsf-1 and actin. * Monomeric Hsf-1 (,80 kDa); ** Dimeric Hsf-1 (,160 kDa); *** Trimeric Hsf-1
(,230 kDa). (B) ARPE-19 cells were treated with 1 mM MGO for 1, 3 or 5 hours and the cell lysates were analyzed by western blot using specific
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induced post-translational modifications of proteins leads to
recruitment of molecular chaperones, in an attempt to repair the
misfolded proteins. CHIP is subsequently recruited and acts as a
switch, directing substrates from protein refolding to protein
degradation. However, our observations suggest that formation of
CHIP- and chaperones-containing large ubiquitinated aggregates
may become difficult to process by either pathway (refolding or
degradation), particularly if the proteasome is also inhibited,
leading to the sequestering of CHIP and molecular chaperones in
such insoluble protein aggregates.
In agreement with data presented in this work, high levels of
MGO and the resulting accumulation of protein aggregates have
been extensively correlated with the loss of cell viability and
increased cell death [25,53,54]. Hsf-1 has been identified as a key
player in the cell response to stress by mediating stress-induced
heat shock gene expression, by virtue of its ability to bind to DNA,
oligomerization and nuclear localization in response to environ-
mental stressors [34,36]. Indeed, this study shows that Hsf-1 is
activated in the presence of increased levels of MGO, as revealed
by increased trimerization and increased transcriptional activity.
Ultimately, the stress induced by MGO appears to be, at least in
part, compensated by the activation of Hsf-1. Activation of Hsf-1
results in overexpression of several heat shock proteins, known to
improve refolding of damaged proteins and to promote cell
survival. This response suggests that cells have finely tuned sensing
mechanisms that counteract abnormal changes induced by stress-
inducers. However, these mechanisms are likely to be compro-
mised under acute and severe forms of stress or under chronic mild
stresses. Indeed, several reports showed that aging and progression
of diabetes are both associated to malfunction and failure of the
Hsf-1 system [55,56], suggesting loss of cell ability to respond to
stress and increased susceptibility to cell damage in later stages of
age-related diseases.
Regulation of Hsf-1 in the presence of MGO is still unclear but
is likely to involve thiol-disulfide exchange, which has been
reported to be a redox-dependent posttranslational modification
mechanism that can regulate the activity and structure of
transcription factors and other proteins [57]. Indeed, NF-kB
[58] and AP-1 [59] were shown to be regulated by a mechanism
that involves formation of nonnative disulfide crosslinks and
oxidation of conserved redox-reactive Cys residues. A similar
mechanism is also likely to be involved in regulation of Hsf-1. For
example, it was shown that Hsf-1 directly senses both heat and
hydrogen peroxide to assemble into a homotrimer in a reversible
and redox-regulated manner [35]. The sensing of both conditions
requires two Cys residues within the Hsf-1 DNA-binding domain
that are engaged in redox-sensitive disulfide bonds. Moreover,
Hsf-1 derivatives in which the Cys residues were mutated are
refractive to stress-inducible trimerization and DNA binding [60].
In further support of this hypothesis, MGO is known to change the
cellular redox status [61], induce the formation of disulfide-
crosslinks and modify the SH-group of Cys residues [62,63]. These
evidences may explain the higher preservation of Hsf-1 homodi-
mers and homotrimers when samples are lysed using low amounts
of b-mercaptoetanol.
Another interesting aspect that is suggested by the current work
is that MGO targets lysine residues, which are major ubiquitin-
acceptor sites. At a first glance it might be expected a general
decrease on the total levels of ubiquitinated proteins in the cells.
However, in this study we observe a clear increase in the levels of
ubiquitinated proteins following treatment with MGO. This
apparent contradiction is not without precedent. Indeed, there
are several reports showing that modification of lysine residues by
processes such as lysine acetylation may either increase or decrease
ubiquitination, depending on the substrate (reviewed in [64]). In
the case of glycation, it is known that CML-modified proteins are
substrates for ubiquitin conjugation [41] and that, for example,
Raf-1 is degraded by an ubiquitin-proteasome-dependent mech-
anism in response to MGO [65], suggesting increased ubiquitina-
tion of glycated proteins and the existence of a crosstalk between
both processes. Considering the data presented in this study, as
well as other reports in the literature, it is likely that glycation on
lysine residues can direct substrates to either refolding or
proteasome degradation. The final fate of a specific substrate is
probably the result of the stability of the modified protein, as well
as of the recruitment of a number of different binding partners that
may divert substrates to specific pathways. However, this is a
matter for further investigation.
As a major conclusion, the data obtained in this work suggests
that accumulation of MGO, which occurs in a variety of situations,
such as diabetes and aging, impairs both the UPS and the protein
quality control dependent on CHIP and molecular chaperones,
leading to accumulation of toxic aggregates and decreased cell
viability. However, these MGO induced changes appear to elicit a
response from the Hsf-1 system, which is crucial to help cells to
cope with cellular stress and to re-establish homeostasis.
Materials and Methods
Cells Culture and Treatments
The human retinal pigment epithelium cell line ARPE-19 (LGC
Promochem, Teddington, UK) was cultured in Ham’s F12/
Dulbecco’s modified Eagle’s medium (DMEM) (1:1) supplemented
antibodies against Hsf-1 and actin. (C) ARPE-19 cells were transiently transfected with the HSE wt (x4)-luciferase or HSE mut (x4)-luciferase vectors and
were treated with 1 mM MGO for 3, 5 or 8 hours. Subsequently, the luciferase activity was determined by luminescence. The quantified results
represent the mean 6 SD of at least three independent experiments. ** p,0.01, significantly different from control; one-way ANOVA (Dunnet’s post
hoc test). (D) ARPE-19 cells were treated with 1 mM MGO for 3, 5 or 8 hours. Total RNA was used to synthesize cDNA, which, in turn, was used as
template to quantify HspB1, HspB2, Hsc70, Hsp70 and Hsp90 mRNA and 18S rRNA through RT-PCR. The quantified results represent the mean 6 SD
of at least three independent experiments. * p,0.05, ** p,0.01, *** p,0.001, significantly different from the respective control; ## p,0.01 and
### p,0.001, significantly different from the corresponding ‘‘MGO 3 h’’ condition; 1 p,0.05, 11 p,0.01, significantly different from the
corresponding ‘‘MGO 5 h’’ condition; one-way ANOVA (Tukey’s post hoc test). (E) ARPE-19 cells were treated with 1 mM MGO for 3, 5 or 8 hours and
the cell lysates were analyzed by western blot using anti-Hsc70, -Hsp90 and -actin antibodies. The quantified results represent the mean 6 SD of at
least three independent experiments. * p,0.05, ** p,0.01 and *** p,0.001, significantly different from the respective control; one-way ANOVA
(Tukey’s post hoc test); ## p,0.01, significantly different from the corresponding ‘‘MGO 5 h’’ condition; one-way ANOVA (Tukey’s post hoc test). (F)
ARPE-19 cells were treated with 1 mM MGO for 1, 3, 5, 8 or 10 hours and the cell lysates were analyzed by western blot using anti-Hsp27, -Hsp70, -
GAPDH and -actin antibodies. (G) ARPE-19 cells, transfected with c-myc tagged Hsf-1, were treated with 1 mM MGO for 1, 3, 5 or 8 hours. c-myc was
immunoprecipitated and immunoprecipitates were probed against c-myc and Hsp90. (H) ARPE-19 cells were treated with 1 mM MGO for 3, 8 or
10 hours and used to assess cell viability through the MTT colorimetric assay. The quantified results represent the mean 6 SD of at least three
independent experiments. * p,0.05, significantly different from control; # p,0.05, significantly different from ‘‘1 mM MGO 8 h’’ condition; one-way
ANOVA (Dunnet’s post hoc test).
doi:10.1371/journal.pone.0013007.g005
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penicillin, 100 mg/ml streptomycin and 250 ng/ml amphotericin
B) and GlutaMax (1x). All media, GlutaMax and non-essential
amino acids were purchased from Invitrogen (Carlsbad, CA,
USA). When appropriated, cells were treated with cycloheximide
(CHX; Sigma-Aldrich, St. Louis, MO, USA), methylglyoxal
(MGO, Sigma-Aldrich, St. Louis, MO, USA) and/or MG132
(Z-LLL-CHO, Calbiochem, San Diego, CA, USA).
Western Blot Analysis
After appropriate treatments, cells were washed twice in
phosphate-buffered saline (PBS), denatured with 26 Laemmli
buffer, boiled at 100uC and sonicated. Whole cell extracts were
resolved by SDS-PAGE and electrophoretically transferred onto
polyvinylidene fluoride (PVDF) membranes. The membranes were
blocked with 5% nonfat milk in TBS-T (20 mM Tris, 150 mM
NaCl, Tween 0.2%, pH 7.6) and probed for several proteins. The
following antibodies were used: mouse anti-actin clone C4 1:1,000
(Millipore-Chemicon, Billerica, MA, USA), mouse anti-ubiquitin
clone P4D1 1:1,000 (Covance, Princeton, NJ, USA), mouse anti-c-
myc clone 9E10 1:500 (Zymed-Invitrogen, Carlsbad, CA, USA),
mouse anti-argpyrimidine 1:500 (kindly provided by Dr. Koji
Uchida from Nagoya University) [20], mouse anti- Hsp70 clone
C92F3A-5 1:1,000 (Stressgen-Enzo Life Sciences, Farmingdale,
NY, USA), rat anti-Hsp90 clone 16F1 1:1,000 (Stressgen-Enzo
Life Sciences, Farmingdale, NY, USA), rat anti-Hsc70 clone 1B5
1:2,000 (Stressgen-Enzo Life Sciences, Farmingdale, NY, USA),
rat anti-Hsf-1 clone 10H8 1:1,000 (Stressgen-Enzo Life Sciences,
Farmingdale, NY, USA), rabbit anti-Hsp40 1:2,000 (Stressgen-
Enzo Life Sciences, Farmingdale, NY, USA), rabbit anti-Hsp27
1:20,000 (Stressgen-Enzo Life Sciences, Farmingdale, NY, USA),
rabbit anti-GAPDH 1:5000 (Cell Signaling, Beverly, MA, USA),
goat anti-STUB1/CHIP 1:500 (Abcam, Cambridge, UK) and
horseradish peroxidase-conjugated secondary goat anti-mouse,
goat anti-rat, goat anti-rabbit and rabbit anti-goat (Bio-Rad,
Hercules, CA, USA). Immunoreactive bands were visualized with
an ECL system (GE Healthcare Bio-Sciences, Uppsala, Sweden).
Determination of Intracellular Concentration of
Methylglyoxal
ARPE-19 cells cultured in 60615 mm plates were lysed with
200 ml of lysis buffer (50 mM Tris-HCl pH 7.4, 250 mM NaCl
and 16 protease inhibitor cocktail), incubated for 1 hour on ice
and briefly sonicated. Protein concentration was determined by
the Coomassie Protein Assay (Pierce-Thermo Scientific, Waltham,
MA, USA). Subsequently, 100 ml of lysate (at a concentration of
1 mg/ml) was mixed with 100 ml HCl (0.2 M) and the intracellular
concentration of MGO was determined based on a previously
reported method [66]. Briefly, 50 ml of sample was mixed with
200 ml of 0.1 M potassium phosphate buffer pH 7.0, 200 mlo f
ethanol and 50 ml of freshly prepared 20 mM DDB (dissolved in
10 mM HCl) (Invitrogen, Carlsbad, CA, USA). The mixture was
incubated at room temperature for at least four hours and then
centrifuged during 10 minutes at 16,000 g. Subsequently, MGO
was determined through reverse-phase HPLC. The HPLC system
consisted of a L-6200A Intelligent Pump, a F-1080 Fluorescence
Detector (Hitachi, Tokyo, Japan) and a Waters mBondapak
TM
C18 column (10 mM, 3.96300 mm) (Waters, Milford, MA, USA).
Mobile phase A was a mixture of 10 mM potassium phosphate
buffer (pH 3.0) and acetonitrile (90/10, v/v). Mobile phase B
consisted of a mixture of acetonitrile and water (70/30, v/v).
Samples (20 ml) were injected and separation was performed with
a linear gradient from 0–100% mobile phase B over 28 minutes.
The flow rate was set at 1.0 ml/min and fluorescence detection
was performed with excitation and emission wavelengths of
352 nm and 385 nm, respectively. Levels of MGO were
determined by integration of peak areas using appropriate external
standards.
Measurement of the 20S Proteasome Activity
Cells were washed twice with PBS, lysed with a Tris buffer
(50 mM Tris pH 7.4, 1 mM DTT) and sonicated. After
centrifugation (16,000 g for 10 minutes at 4uC), protein concen-
tration was determined using the Coomassie method and 40 mgo f
protein was incubated with the following fluorogenic substrates:
100 mM Suc-LLVY-MCA for the chymotrypsin-like activity
(Biomol-Enzo Life Sciences, Farmingdale, NY, USA); 25 mM
Boc-LRR-MCA for the trypsin-like activity (Biomol-Enzo Life
Sciences, Farmingdale, NY, USA); 150 mM Z-LLE-MCA for the
caspase-like activity (Calbiochem, San Diego, CA, USA). The
proteasome activities were monitored during 1 hour at 37uC, in
periods of 5 minutes (excitation wavelength at 380 nm; emission
wavelength at 460 nm). Absorbance was measured on a Biotek
Synergy HT spectrophotometer (Biotek, Winooski, VT, USA),
using the Gen 5 software to monitor the results (Biotek, Winooski,
VT, USA).
Transient Transfection
One day before transfection, cells were seeded in 60615 mm
plates in 2.5 ml of medium so that the cells were 90% confluent at
the time of transfection. 4 mg of plasmid DNA were used per dish
and transfections were carried out using Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s
specifications. The following plasmids were used: pcDNA3.1 c-
myc-CHIP wt, pcDNA3.1 c-myc-CHIP K30A, pcDNA3.1 c-myc-
CHIP H260Q (originally provided by Dr. C. Patterson from the
North Carolina University) [67]; pcDNA3.1 hHsf-1-c-myc
(provided by Dr. Lea Sistonen from the University of Turku,
Turku, Finland) [68]; pGL4.23 HSE wt (x4)-Luciferase, pGL4.23
HSE mut (x4)-Luciferase (provided by Dr. Ueli Schibler from the
University of Geneva, Switzerland) [69].
Luciferase-Reporter Assay
Subconfluent ARPE-19 cells, plated in 24-well plates, were
transfected with pGL4.23 HSE wt (x4)-Luciferase or pGL4.23
HSE mut (x4)-Luciferase [69], using Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA, USA). The plasmids pGL4.23 HSE-Luciferase
contain four copies of the wild-type or mutated form of a heat
shock element (HSE) and a minimal promoter upstream of a firefly
luciferase reporter gene [69]. The mutant form does not bind the
transcription factor Hsf-1. Twenty-four hours after transfection,
cells were treated as mentioned and then assayed for luciferase
activity, which was measured using a LMax II 384 ROM v1.04
reader and SoftMax Pro 5 software (Molecular Devices,
Sunnyvale, CA, USA), as described by the manufacturer’s
protocol.
Real-Time PCR
Following the relevant treatments, total RNA was purified
according to the manufacturer’s specifications of Qiagen RNeasy
mini kit (Qiagen, Valencia, CA, USA) and treated with RNase-
free DNase I (GE Healthcare Bio-Sciences, Uppsala, Sweden).
SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA,
USA) and random hexadeoxynucleotide primers were used to
synthesize cDNA. For the cDNA real-time PCR, it was used the
SYBR Green PCR master mix (Bio-Rad, Hercules, CA, USA),
according to the manufacturer’s instructions, and the cDNA
MGO in Protein Quality Control
PLoS ONE | www.plosone.org 8 September 2010 | Volume 5 | Issue 9 | e13007amplification was performed using the following sets of primers:
hHsc70 forward 59-ATACCTCCTGCACCCCGAG-39; hHsc70
reverse 59-TTGCTCAAACGGCCCTTGTC-39; hHsp70 for-
ward 59-GTGCAGTTG CCTACAGGATTAAC-39; hHsp70
reverse 59-TCGGCTGTCTCCTTCAGTTTG-39; hHsp90 for-
ward 59-TTCCACGTCTCTGCATTCC-39; hHsp90 reverse 59-
CTTGGGTCTG GGTTTCCTC-39; hHspB1 forward 59-GC-
TGACGGTCAAGACCAAGG-39; hHspB1 reverse 59-GGGG-
GCAGCGTGTATTTCC-39; hHspB2 forward 59-C GAGTAC-
GAATTT GCCAACC-39; hHspB2 reverse 59-AGTAGCCA-
TGGTAGAGTGTG-39; 18S rRNA forward 59-GTCTGCC-
CTATCAACTTTC-39; 18S rRNA reverse 59-TTCCTTGG-
ATGTG GTAGC-39 (endogenous control). The real time PCR
analyses were conducted on a ABI Prism 7000 quantitative PCR
system (Applied Biosystems, Foster City, CA, USA).
Immunoprecipitation
Cells cultured in 60615 mm plates were washed twice with
PBS, scraped off the dishes and collected in ice-cold PBS. Pellets
were resuspended in 100 ml of 50 mM Tris-HCl pH 7.4, 150 mM
NaCl, 10 mM IOD, 2 mM PMSF, 20 mM Na3MoO4, 0.25%
NP-40 and protease inhibitor cocktail (Roche Applied Science,
Indianapolis, IN, USA) and incubated for 30 minutes on ice.
Following centrifugation at 16,000 g for 10 minutes, supernatants
were transferred to new tubes, 2.5 mg of anti-c-myc or anti-Hsp40
were added and incubated overnight at 4uC with gentle agitation.
Thereafter, 50 ml of protein G-Sepharose (GE Healthcare Bio-
Sciences, Uppsala, Sweden) were added and incubations proceed-
ed at 4uC for 2 hours. Beads were washed 3 times and the
immunoprecipitated proteins were eluted with 26Laemmli buffer
and boiled at 100uC. Eluted samples were used to perform western
blot analyses.
Protein derivatization with DNPH
After the treatments, ARPE-19 cells were washed twice with ice-
cold PBS and lysed in Tris-HCl pH 7.6 supplemented with 1%
NP-40 and protease inhibitor cocktail (Roche Applied Science,
Indianapolis, IN, USA). For derivatization of carbonyl-containing
proteins, equal amounts of proteins were mixed with equal volume
of 10 mM 2,4-dinitrophenylhydrazine (DNPH) in 10% trifluor-
oacetic acid and incubated at room temperature for 15 minutes.
The reaction was stopped by precipitation of proteins with 20%
trichloroacetic acid (TCA). The pellet was washed with ethylace-
tate:ethanol (1:1) to remove free DNPH. Subsequently, the pellet
was solubilized with Laemmli buffer. Samples were resolved by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to PVDF membranes. The membrane was probed with
antibody to dinitrophenylhydrazone derivatives (Dako, Glostrup,
Denmark).
MTT cell viability assay
After the treatments, ARPE-19 cells seeded onto 24-well plates
were washed twice with PBS and incubated with 0.5 mg/ml MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; In-
vitrogen, Carlsbad, CA, USA], solubilized in Krebs buffer
(130 mM NaCl, 4 mM KCl, 1.5 mM MgCl2, 1 mM CaCl2,
6 mM glucose, 10 mM HEPES, pH 7.4), for 2 hours at 37uCi na
cell culture incubator. Subsequently, supernatants were removed
and the precipitated dye was dissolved in 300 ml 0.04 M HCl (in
isopropanol) and colorimetric quantified at a wavelength of
570 nm, with wavelength correction at 620 nm, using a Biotek
Synergy HT spectrophotometer (Biotek, Winooski, VT, USA).
Statistical Analysis
Data are reported as the means 6 standard deviation (SD) of at
least three independent experiments. Comparison between
multiple groups was performed by one-way analysis of variance
test (ANOVA) using GraphPad Prism 5.0 software (GraphPad
Software). For comparison between two groups, the paired t test
was used. In all cases, p,0.05 was considered significant.
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